NIA Impact Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
136,769
-10,828
-7% -$243K 1.28% 35
2026
Q1
$3.33M Sell
147,597
-5,365
-4% -$123K 1.48% 26
2025
Q4
$3.64M Sell
152,962
-10,625
-6% -$264K 1.22% 35
2025
Q3
$4.31M Buy
163,587
+41,389
+34% +$1.06M 1.4% 27
2025
Q2
$3.49M Sell
122,198
-127
-0.1% -$3.41K 1.21% 30
2025
Q1
$3.05M Buy
+122,325
New +$2.91M 1.13% 33

Other funds holding FMS

NIA Impact Advisors's FMS Position: Q2 2026 in Review

NIA Impact Advisors reduced its Fresenius Medical Care (FMS) stake by 7.3% in Q2 2026, selling an estimated $243K and leaving 136,769 shares worth $3.09M. The position accounts for 1.28% of the portfolio, ranked #35.

NIA Impact Advisors first reported a position in FMS in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.31M in Q3 2025. 235 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • NIA Impact Advisors held 136,769 shares of Fresenius Medical Care worth $3.09M as of Q2 2026.
  • NIA Impact Advisors sold 10,828 Fresenius Medical Care shares in Q2 2026, an estimated $243K.
  • Fresenius Medical Care made up 1.28% of NIA Impact Advisors's portfolio in Q2 2026, its #35 holding.
  • NIA Impact Advisors first reported a position in Fresenius Medical Care in Q1 2025 and has held it in 6 quarters since.
  • NIA Impact Advisors's Fresenius Medical Care position peaked at $4.31M in Q3 2025.
  • 235 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.